BioWorld - Tuesday, January 14, 2025

BioWorld Science

Aug. 25, 2020

View Archived Issues

Capsid-like particles displaying an HA trimer: a promising universal flu vaccine candidate

Read More

New partner in crime for AHR

Read More

Multiple sclerosis' early days

Read More

New ADCs including tandem-cleavage linkers show improved stability and toxicity

Read More

Epigenetic problems contribute to Parkinson's disease

Read More

Roche reports the discovery of novel CYP11B2 inhibitors

Read More

Tocilizumab may prevent risk of invasive mechanical ventilation or death in severe COVID-19

Read More

Bayer, The Broad Institute describe new PDE3A and/or PDE3B inhibitors

Read More

FDA clears IND application for phase Ib study of NT-I7 plus Kymriah in r/r LBCL

Read More

Positive topline data presented from phase III CONTESSA study of tesetaxel

Read More

Orexin receptor type 1 antagonists discovered at Heptares Therapeutics

Read More

Hubei Bio-Pharmaceutical, Humanwell Healthcare patent E-NPP 2 inhibitors

Read More

Bristol-Myers Squibb discovers TYK2 inhibitors

Read More

New adenosine A2A/A2B receptor antagonists identified at Incyte

Read More

Pivotal phase III INSPIRE study of rigosertib in MDS does not meet primary endpoint

Read More

Keytruda receives two new approvals in Japan

Read More

Imugene begins phase I study of IMU-201 in NSCLC

Read More

Early clinical reports suggest utility of Aggrastat for COVID-19-related thrombotic complications

Read More

AstraZeneca begins first-in-human study of AZD-7442 for prevention and treatment of COVID-19

Read More